Relaxation properties of a dual-labeled probe for MRI and neutron capture therapy

Magnetic Resonance in Medicine

Volumn 42, Issue 1, 1999, Pages 32-36

  Tatham, Alicia T ^a   Nakamura, H ^b   Wiener, E C ^a   Yamamoto, Y ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

Albumin; Contrast agents; Gadolinium; Magnetic resonance imaging; Neutron capture therapy

Indexed keywords

BORON; GADOLINIUM; MAGNETIC RESONANCE IMAGING; MAGNETISM; NEUTRONS;

ALBUMIN; BORON NEUTRON CAPTURE THERAPY; CARBORANE DERIVATIVES; CONTRAST AGENT; INDIRECT MEASUREMENTS; NEUTRON CAPTURE THERAPY; NUCLEAR MAGNETIC RELAXATION DISPERSION; ROTATIONAL CORRELATION TIME;

GADOLINIUM COMPOUNDS;

BORON DERIVATIVE; CARBORANE DERIVATIVE; GADOLINIUM PENTETATE DERIVATIVE;

ARTICLE; NEUTRON CAPTURE THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; RADIATION DOSE; RADIATION PHYSICS;

EID: 0010321910     PISSN: 07403194     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2594(199907)42:1<32::AID-MRM6>3.0.CO;2-5     Document Type: Article

References (21)

1. Feakes DA, Shelly K, Hawthorne MR Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes. Proc Natl Acad Sci USA 1995;92:1367-1370.
2. Kahl S, Li J. Synthesis and characterization of a boronated metallophthalocyanine for boron neutron capture therapy. Inorg Chem 1996;35:3878-3880.
3. Nemoto H, Wilson JG, Nakamura H, Yamamoto Y. Polyols of a cascade type as a water-solubilizing element of carborane derivatives for boron neutron capture therapy. J Org Chem 1992;57:435-435.
4. Ono K, Masunaga SI, Kinashi Y, Takagaki M, Akaboshi M, Kobayashi T, Akuta K. Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy. Int J Radiat Oncol Biol Phys 1996;34:1081-1086.
5. Zhao Y, Song R, Wang X, Liu Y. A combination of gadolinium and boron compounds for use in Gd-BNCT. Adv Neutron Capture Ther 1997;II:451-455.
6. Berger B, Fischer CO, Lawaczeck R, Platzek J, Schwartz-Porsche D, Semmler W. neutron capture therapy (NCT) with a macrocyclic Gd-complex. Adv Neutron Capture Ther 1997;II:440-446.
7. Allen DA, Beynon TD, Perks J. In vivo on-line 10B(n,a) three-dimensional dosimetry using binary Gabor Zone plate encoded g-ray holography. Adv Neutron Capture Ther Med Phys 1997;I:229-236.
8. Arlinghaus HF, Spaar MT, Switzer RC, Kabalka GW. Imaging of boron in tissue at the cellular level for boron neutron capture therapy. Anal Chem 1997;69:3169-3176.
9. Flego M, Nicolay K, Watkins P. Three-dimensional back-projection reconstruction methods for magnetic resonance imaging (MRI) of nuclei with short relaxation times. Adv Neutron Capture Ther Med Phys 1997;I:289-293.
10. Bradshaw KM, Schweizer MP, Glover GH, Hadley JR, Tippets R, Tang P, Davis WL, Heilbrun MP, Johnson S, Ghanem T. BSH distribution in the canine head and a human patient using 11B MRI. Magn Reson Med 1995;34:48-56.
11. Kabalka GW, Smith GT, Dyke JP, Reid WS, Longford CP, Roberts TG, Reddy NK, Buonocore E, Hubner KF. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning. J Nucl Med 1997;38:1762-1767.
12. Geraldes CFGC, Urbano AM, Alpoim MC, Sherry AD, Kuan K-T, Rajagopalan R, Maton F, Muller RN. Preparation, physico-chemical characterization, and relaxometry studies of various gadolinium (III)-DTPA-bis(amide) derivatives as potential magnetic resonance contrast agents. Magn Reson Imaging 1995;13:401-420.
13. Schwarzbauer C, Syha J, Haase A. Quantification of regional blood volumes by rapid T1 mapping. Magn Reson Med 1993;29:709-712.
14. Nemoto H, Cai J, Yamamoto Y. A new synthetic method of all carboxylate-free DTPA derivatives and its application to the synthesis of Gd-carborane complex. Tetrahedron Lett 1996;37:539-542.
15. Wiener E, Brechbiel M, Brothers H, Magin R, Gansow O, Tomalis D, Lauterbur P. Dendrimer-based metal chelates: a new class of magnetic resonance imaging contrast agents. Magn Reson Med 1994;31:1-8.
16. Cantor CR, Schimmel PR. Biophysical chemistry part III: The behavior of biological macromolecules. San Francisco: WH Freeman and Company; 1980. p 1340-1342.
17. Koenig SH, Ahkong QF, Brown RD III, Lafleur M, Spiller M, Unger E, Tilcock C. Permeability of liposomal membranes to water: results from the magnetic filed dependence of T1 of solvent protons in suspensions of vesicles with entrapped paramagnetic ions. Magn Reson Med 1992;23:275-286.
18. Demant EJF, Friche E. Equilibrium binding of anthracycline cytostatics to serum albumin and small unilameller phospholipid vesicles as measured by gel filtration. Biochem Pharmacol 1998;55:27-32.
19. 17O NMR study. Inorg Chem 1996;35:3375-3379.
20. th Scientific Meeting, 1997, vol 3. p 1575.
21. Lauffer RB, Randall B. Paramagnetic metal complexes as water proton relaxation agents for NMR imaging: theory and design. Chem Rev 1987;87:901-927.